{"name": "NeRRe Therapeutics",
 "permalink": "nerre-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/nerre-therapeutics",
 "homepage_url": "",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": null,
 "number_of_employees": null,
 "founded_year": 2012,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Thu Dec 20 14:23:38 UTC 2012",
 "updated_at": "Tue Apr 09 05:57:11 UTC 2013",
 "overview": "\u003Cp\u003ENeRRe Therapeutics Ltd. operates as a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists. The company was founded in 2012 and is based in Stevenage, United Kingdom.\u003C/p\u003E",
 "image": null,
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$18.4M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.biospace.com/News/ex-glaxosmithkline-neuroscientists-nab-18-4/282761/Source=TopBreaking",
    "source_description": "Ex-GlaxoSmithKline (GSK) Neuroscientists Nab $18.4 Million Series A Financing for New Co. NeRRe Therapeutics Ltd",
    "raised_amount": 18400000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 12,
    "funded_day": 19,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Gunnels Wood Rd, ",
    "address2": "Stevenage,",
    "zip_code": " SG1, ",
    "city": " Hertfordshire",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}